KARL A. WESTERN, M.D.; MYRON G. SCHULTZ, D.V.M., M.D., D.C.M.T.
This content is PDF only. Please click on the PDF icon to access.
To the Editor: A recent letter in this column by Drs. Emmer and DeVita (1) reports the onset of reversible kidney damage in a 50-year-old woman who was receiving pentamidine isethionate for biopsy-proved Pneumocystis carinii pneumonia. The correspondents warn that renal toxicity should be carefully watched for in patients given this drug. We support this warning, but at the same time we hope that it will not be overinterpreted, for we do not believe that renal toxicity is a life-threatening or a major limiting factor in the use of pentamidine. Pentamidine is usually given for life-threatening diseases, and the reported
WESTERN KA, SCHULTZ MG. PENTAMIDINE NONTOXICITY. Ann Intern Med. ;70:234–235. doi: 10.7326/0003-4819-70-1-234_2
Download citation file:
Published: Ann Intern Med. 1969;70(1):234-235.
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use